Caris Life Sciences Inc
(CAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 50,814 | 28,202 | 13,556 | -26,953 | 19,047 |
| Depreciation Amortization | 36,753 | 23,082 | 19,514 | 68,256 | 10,774 |
| Income taxes - deferred | 3,883 | 3,069 | -1,130 | -593 | -1,754 |
| Accounts receivable | -3,842 | -10,390 | 7,243 | -4,417 | -3,776 |
| Other Working Capital | -3,594 | -3,055 | 1,322 | 969 | -11,080 |
| Other Operating Activity | -11,909 | 1,516 | -9,707 | -9,824 | -13,477 |
| Operating Cash Flow | $72,105 | $42,424 | $30,798 | $27,438 | $-266 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -461,103 | -174,908 | -7,684 | -169,376 | -200,428 |
| Net Acquisitions | N/A | N/A | N/A | -14,566 | N/A |
| Sale Of Investment | 24,886 | 12,367 | 5,840 | 99,773 | 113,402 |
| Other Investing Activity | 6,080 | 5,333 | 5,532 | 6,563 | 3,991 |
| Investing Cash Flow | $-430,137 | $-157,208 | $3,688 | $-77,606 | $-83,035 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 558,401 | 135,800 | 15,000 | 134,600 | 138,100 |
| Debt Issued | N/A | N/A | 11,345 | 2,944 | N/A |
| Debt Repayment | N/A | N/A | -4,559 | -3,308 | -38,025 |
| Common Stock Issued | N/A | 22,353 | 0 | 10,767 | 78,117 |
| Dividend Paid | N/A | N/A | N/A | N/A | -804 |
| Other Financing Activity | -200,353 | -43,133 | -70,793 | -74,340 | -106,019 |
| Financing Cash Flow | $358,048 | $115,020 | $-49,007 | $70,663 | $71,369 |
| Exchange Rate Effect | -331 | -335 | 478 | -393 | 6 |
| Beginning Cash Position | 14,393 | 14,492 | 28,535 | 8,433 | 20,359 |
| End Cash Position | 14,078 | 14,393 | 14,492 | 28,535 | 8,433 |
| Net Cash Flow | $-315 | $-99 | $-14,043 | $20,102 | $-11,926 |
| Free Cash Flow | |||||
| Operating Cash Flow | 72,105 | 42,424 | 30,798 | 27,438 | -266 |
| Capital Expenditure | -491,927 | -206,830 | -31,353 | -189,733 | -219,666 |
| Free Cash Flow | -419,822 | -164,406 | -555 | -162,295 | -219,932 |